GSD:CC News and Press, Devonian Health Group Inc.

GSD:CC - Devonian Health Group to Participate in Renmark's Chicago Virtual Non-Deal Roadshow Series on Wednesday, July 17, 2024

Devonian Health Group Inc. (“ Devonian ” or the “ Company ”) ( TSXV: GSD; OTCQB: DVHGF ), announced today that they will be participating in Renmark Financial Communications Inc.’s (“ Renmark ”) live Virtual Non-Deal Roadshow Series...

GSD:CC - Devonian Health Group to Participate in Renmark's Los Angeles Virtual Non-Deal Roadshow Series on Wednesday, July 10, 2024

Devonian Health Group Inc. (“ Devonian ” or the “ Company ”) ( TSXV: GSD; OTCQB: DVHGF ), announced today that they will be participating in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series in Los Angeles on July 10, 2024...

GSD:CC - Devonian Health Group to Participate in Renmark's Boston Virtual Non-Deal Roadshow Series on Wednesday, June 26, 2024

Devonian Health Group Inc. (“ Devonian ” or the “ Company ”) ( TSXV: GSD; OTCQB: DVHGF ), announced today that they will be participating in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series in Boston on June 26, 2024 to d...

GSD:CC - Devonian Health Group Reports Third Quarter 2024 Financial Results and Business Update and Announces Engagement of Investor Relations Firm

Third quarter revenues increased 1,162% year over year Third quarter net loss for the quarter of $ 0.002 per share Renmark Financial Communications selected for investor relations Devonian Health Group Inc. (“ Devonian ” or the “ Co...

GSD:CC - Devonian Appoints André P. Boulet to Chairman of the Board and Chief Operating Officer

Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced t...

GSD:CC - Devonian Health Group Reports Second Quarter 2024 Financial Results and Business Update

Devonian Health Group Inc. (“ Devonian ” or the “ Company ”) ( TSXV: GSD; OTCQB: DVHGF ), today announced financial results for its second quarter ended on January 31, 2024. Management Comments " This has been a truly transformative quarter fo...

GSD:CC - Devonian Announces Closing of a Private Placement of Units

Not for distribution to United States newswire services or for dissemination in the United States Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation...

GSD:CC - Devonian Names Kathryn J. Gregory to the Board of Directors and Grants Stock Options

Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced t...

GSD:CC - Devonian Announces that its Subsidiary, Altius, Launches Authorized Generic of Dexlansoprazole (Dexilant®) in Canada

Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, is pleased ...

GSD:CC - Devonian Announces a $2.16 Million Secured Term Loan Following Repayment of $3.5 Million Long Term Loan

Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced t...

Company Name:	Devonian Health Group Inc.
Stock Symbol:	GSD:CC
Market:	TSXVC
Website:	groupedevonian.com